leisure time -WSS

leisure time

author：entertainment 2025-10-01 21:33:29 - browse：74

Adam's take main illustration — Molly Ferguson/STAT

Thoughts about Cytokinetics after Wednesday night’s financing announcement:

1. Management is raising $500 million at $51 per share, when the stock was at $45 per share before the aficamtem study readout in December. That’s shocking. Somehow, management has not only removed all the M&A premium from the stock, but much or most of aficamtem’s value, too.

2. Omecamtiv’s resurrection: Are you kidding me? No one thinks bringing back this heart failure drug is a good idea, except management. Making it worse, the terms of the Royalty Pharma loan are, again, shocking. All the risk is borne by Cytokinetics. Royalty, in fact, may do better if omecamtiv fails.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： JPM 2024: Verve Therapeutics looks to mainstream genome editing

WSS

Idaho abortion case may prompt more restrictions in other states

What affirmative action's end means to a medical student

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Skip the lead apron during X

STAT wants to know your pick for a great summer read or listen

What affirmative action's end means to a medical student

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

The high cost of giving birth even with insurance

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

23andMe had bad news about my health. I wish a person had delivered it

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

United colonoscopy coverage change 'may cost lives,' doctors say

How Robert F. Kennedy Jr. distorted vaccine science

ChatGPT in medicine: STAT answers readers' burning questions

Beware reading your test results before your doctor does

Continuity nursing helped my family in our darkest PICU moments

Generative AI mines health records to identify patients’ social needs

focus

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Canadians with cystic fibrosis outlive Americans by a decade

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Skip the lead apron during X

hotspot

focus

focus

entertainment